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A Neurotrophin Signaling Cascade Coordinates
Sympathetic Neuron Development through Differential
Control of TrkA Trafficking and Retrograde Signaling
innervation (Francis et al., 1999). Interestingly, both ge-
netic and biochemical analyses have shown that NT-3,
like NGF, promotes survival of sympathetic neurons via
the receptor tyrosine kinase TrkA rather than its high-
affinity receptor TrkC. Indeed, no deficits in sympathetic
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neuron survival have been observed in TrkC null miceHoward Hughes Medical Institute
(Fagan et al., 1996; Tessarollo et al., 1997), sympatheticThe Johns Hopkins University School of Medicine
neurons derived from TrkC null mice can survive in vitroBaltimore, Maryland 21205
in the presence of NT-3 (Davies et al., 1995), and NT-32 Department of Neurobiology and Behavior
activates TrkA in sympathetic neurons (Belliveau et al.,The State University of New York at Stony Brook
1997). In contrast, an NT-3 variant that activates TrkCStony Brook, New York 11794
but not TrkA is incapable of supporting survival of sym-
pathetic neurons (Belliveau et al., 1997). Furthermore,
sympathetic neurons die in both NT-3 null and NGF nullSummary
mice at a time when these neurons express high levels
of TrkA and low or negligible levels of TrkC (Fagan et al.,A fundamental question in developmental biology is
1996; Francis et al., 1999). These observations support ahow a limited number of growth factors and their cog-
model in which both NGF and NT-3 signal via TrkA atnate receptors coordinate the formation of tissues and
the same developmental stage to support survival oforgans endowed with enormous morphological com-
sympathetic neurons.plexity. We report that the related neurotrophins NGF
Along with TrkA, the p75 neurotrophin receptor, whichand NT-3, acting through a common receptor, TrkA,
binds with comparable affinity to each of the neuro-are required for sequential stages of sympathetic axon
trophins (Bibel and Barde, 2000), also plays an essentialgrowth and, thus, innervation of target fields. Yet, while
role in the development of the sympathetic nervous sys-NGF supports TrkA internalization and retrograde sig-
tem. Genetic evidence has revealed that p75 modulatesnaling from distal axons to cell bodies to promote
neurotrophin-dependent survival in vivo (Brennan et al.,neuronal survival, NT-3 cannot. Interestingly, final tar-
1999), and unliganded or BDNF bound p75 may directlyget-derived NGF promotes expression of the p75 neu-
promote apoptosis of sympathetic neurons (Bamji et al.,rotrophin receptor, in turn causing a reduction in the
1998). Interestingly, in vitro experiments indicate thatsensitivity of axons to intermediate target-derived
p75 modulates NT-3’s ability to activate TrkA. In cellNT-3. We propose that a hierarchical neurotrophin sig-
lines, NT-3 activates TrkA efficiently when TrkA is over-naling cascade coordinates sequential stages of sym-
expressed (Hempstead et al., 1992) or when p75 levelspathetic axon growth, innervation of targets, and sur-
are reduced (Benedetti et al., 1993; Clary and Reichardt,vival in a manner dependent on the differential control
1994). In addition, NT-3 can more effectively supportof TrkA internalization, trafficking, and retrograde axo-
survival of sympathetic neurons established from em-nal signaling.
bryonic mice at times when p75 expression is low (Da-
vies et al., 1995) or from p75-deficient mice (Lee et al.,Introduction
1994b). These findings, taken together, have led to the
idea that both NT-3 and NGF are required for survivalPostganglionic sympathetic neurons have long served
of sympathetic neurons when their axons are extending
as an amenable model to study the molecular events
toward and innervating target fields. Since NT-3 is highly
underlying neuronal survival, axon growth, and the elab-
expressed by blood vessels along which sympathetic
oration of dendrites. While the requirement of the neuro- axons extend, intermediate target-derived NT-3 may
trophin Nerve Growth Factor (NGF) as a final target- provide retrograde trophic support until sympathetic ax-
derived survival factor for sympathetic neurons is well ons innervate final targets and acquire target-derived
established (Levi-Montalcini, 1987; Crowley et al., 1994), NGF. Yet, such a model is inconsistent with the finding
the relative contribution of factor(s) released by interme- that the periods of NT-3 and NGF dependence for sur-
diate targets, such as the vasculature, to growth and vival are essentially identical (Francis et al., 1999). It is
survival of these neurons is less clear. Intriguingly, the also unclear how these neurotrophins and other growth
related neurotrophin NT-3 is crucial for sympathetic neu- factors coordinate the extension of axons within inter-
ron survival in vivo (Ernfors et al., 1994; Farinas et al., mediate and, ultimately, in final target fields. Nor do
1994; Francis et al., 1999), which suggests that NT-3 current models fully define a role for p75, which, in addi-
may act as an intermediate and/or final target-derived tion to its effects on survival, is crucial for innervation
survival factor for these neurons. Consistent with this of at least some sympathetic targets (Lee et al., 1994a).
idea is the finding that NT-3 is expressed at high levels Thus, a unifying model for how NGF, NT-3, TrkA, and
in intermediate targets, particularly in the vasculature, p75 coordinate axon growth along intermediate targets,
as well as in various end organs receiving sympathetic final target innervation, and retrograde survival of sym-
pathetic neurons remains to be established.
At the molecular level, NGF acting through TrkA recep-*Correspondence: dginty@jhmi.edu
3 These authors contributed equally to this work. tors initiates both growth- and survival-promoting signal
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transduction pathways, which include the Ras/Rap1- glia at E15.5 is impaired in NT-3 null mice (Figures 1A
and 1B). Fewer axons from the SCG are found associ-Erk and PI3-kinase effector pathways (Huang and Rei-
ated with the carotid artery in NT-3/ mice, and thosechardt, 2003). Yet, NGF, which acts on TrkA receptors on
present are shorter than axons of littermate controls.distal axons, must support survival of morphologically
Moreover, projections from another paravertebral sym-complex neurons whose cell bodies are located millime-
pathetic ganglion, the stellate ganglion, which extendters, centimeters, or more from distal axons. Thus, the
toward the heart and other thoracic targets, are shortermechanisms by which NGF and other growth factors
in NT-3/ mice as compared to their littermates. Whilesupport long-range retrograde survival signaling, from
sympathetic axons course along the ventricles of E15.5distal axons to cell bodies, have been the topic of much
wild-type mice, few if any fibers are observed ap-interest, and several models have been proposed to
proaching the hearts of NT-3 mutants (Figures 1C andexplain the basis of retrograde signaling (Ginty and
1D). The NT-3 dependence of axon growth is also ob-Segal, 2002). Of these, the “Signaling Endosome” model,
served for neurons whose cell bodies are located inin which retrograde signals are carried by endosomes
prevertebral sympathetic ganglia, including mesentericcontaining NGF and activated TrkA, has gained consid-
ganglia, since sympathetic axons extending along theerable support. Neurotrophins promote internalization
mesenteric arteries are shorter and less developed inof Trks, some of which are then retrogradely transported
E15.0 NT-3/ embryos (Figure 1F) as compared to con-in their activated, autophosphorylated state to cell bod-
trol littermates (Figure 1E). This failure of neurons toies (Delcroix et al., 2003; Tsui-Pierchala and Ginty, 1999;
properly extend along intermediate targets is not a re-Watson et al., 2001). Importantly, Trk catalytic activity
flection of excess neuronal loss at these early timeand autophosphorylation within cell bodies is crucial
points, since nearly identical numbers of sympatheticfor several tyrosine phosphorylation events (Senger and
neurons are found in E15.5 NT-3 null and wild-type con-Campenot, 1997), CREB Ser133 phosphorylation and
trols (Figure 1G), as previously described (Francis et al.,gene expression (Riccio et al., 1997; Watson et al., 1999),
1999). These axon growth deficiencies stand in contrastand survival (Ye et al., 2003). The evidence that NT-3 is
to those observed in NGF null mice, which exhibit targetcritical for sympathetic neuron survival in vivo raises the
organ innervation defects but relatively normal axonal
possibility that this intermediate target-derived neuro-
growth along the vasculature around the SCG, stellate,
trophin employs signaling endosomes to support sur-
and mesenteric ganglia (Glebova and Ginty, 2004).
vival and gene expression in developing sympathetic
Taken together with the finding that the vasculature ex-
neurons in a manner similar to target-derived NGF. Here, presses high levels of NT-3 (Francis et al., 1999; Scaris-
we ask how the related neurotrophins NGF and NT-3 brick et al., 1993), these observations indicate that NT-3
and their receptors TrkA and p75 orchestrate the estab- supports growth of proximal sympathetic axons along
lishment of the sympathetic nervous system. the vasculature, an intermediate target.
As expected because of the proximal projection de-
fects, sympathetic innervation of many end organs, ex-
Results amined at later gestational ages, is substantially attenu-
ated in the absence of NT-3. Reduced levels of
Both NGF and NT-3 Contribute to Growth sympathetic innervation were observed in E16.5 NT-3/
of Sympathetic Neuron Axons In Vivo mice in the heart, duodenum, brown fat (Figures 2A–2F),
We sought to understand how the related neuronal thymus, stomach, pancreas, kidney, and bladder (data
growth factors NGF and NT-3 coordinate the establish- not shown). Moreover, at postnatal day 0.5, the hearts of
ment of the sympathetic nervous system, since both of NT-3/; Bax/mice, and, as recently reported, NGF/;
these neurotrophins are crucial for survival of sympa- Bax/ mice (Glebova and Ginty, 2004) in which sympa-
thetic neurons in vivo. Recent findings indicate that NGF thetic neuron apoptotic cell death is eliminated because
is critical for sympathetic innervation of target organs of deletion of the gene encoding proapoptotic factor
by neurons whose cell bodies reside within both para- Bax showed markedly reduced levels of sympathetic
vertebral and prevertebral sympathetic ganglia but not innervation as compared to Bax/ controls (Figures
for proximal projections of sympathetic axons along the 2G–2J). Together with our recent findings (Glebova and
vasculature (Glebova and Ginty, 2004). To determine Ginty, 2004), these results indicate that both NT-3 and
whether NT-3 is crucial for sympathetic axon outgrowth NGF are critical for sympathetic axon growth in vivo.
in vivo, a whole-mount tyrosine hydroxylase immunohis- NT-3 supports proximal axon extension along the vascu-
tochemistry assay was employed. This assay allows us lature and subsequent innervation of several effector
to visualize the extent of axonal growth along intermedi- organs, whereas NGF is crucial for final target in-
ate targets at E15.5 and innervation of several peripheral nervation.
target tissues at E16.5 in both NT-3 null mice and their
control littermates. These early stages of sympathetic NT-3, like NGF, Can Activate TrkA Locally in Distal
neuron development are ideal for our measurements, Axons of Sympathetic Neurons to Mediate
because intermediate target innervation can be as- Neurite Outgrowth
sessed prior to the period of excess sympathetic neu- The findings that NT-3 is expressed along intermediate
ronal death in NT-3 null mice, which is first evident at and within final targets and that axon growth is attenu-
E17.5 (Francis et al., 1999; Wyatt et al., 1997). ated in mice lacking NT-3 suggest that its in vivo function
We find that growth of proximal sympathetic axons in the developing sympathetic nervous system is to pro-
vide direct support of axon growth. We therefore usedalong the vasculature around the superior cervical gan-
NGF and NT-3 Coordinate Sympathetic Development
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Figure 1. NT-3 Is Required for Outgrowth of Proximal Projections from Sympathetic Ganglia
(A–F) NT-3 is required for the growth of proximal projections from paravertebral and prevertebral sympathetic ganglia. Whole-mount tyrosine
hydroxylase (TH) immunohistochemistry reveals a deficit in sympathetic axonal growth from the superior cervical ganglia (B) and stellate
ganglia (D) at E15.5 and along the mesenteric arteries at E15.0 (F) of NT-3/ mice, as compared to littermate controls (A, C, and E). Dashed
lines outline the ganglia, while arrows/arrowheads indicate the proximal projections. (G) Cell counts reveal no deficits in cell number in the
superior cervical ganglia at E15.5 in NT-3/ mice as compared to littermate wild-type controls. Results are presented as mean  SEM of
neuron number from three wild-type and three NT-3/ mice. Scale bars, 100 m (A-B, C-D, E-F). n  2 (NT-3/; E15.0) and n  4 (NT-3/;
E15.0); n  3 (NT-3/; E15.5) and n  3 (NT-3/; E15.5).
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compartmentalized cultures of sympathetic neurons to
test whether NT-3 added directly and exclusively to dis-
tal axons supports axonal extension. This model system
allows for the separation of distal axons from cell bodies
and proximal axons and the application of growth fac-
tors exclusively to distal axons (see Figure 4A). The
broad-spectrum caspase inhibitor BAF (50 M) was
added to cell bodies in these experiments so that axon
growth responses could be assessed in the absence of
complications of apoptosis. We found that NT-3, like
NGF, added exclusively to distal axons of compartmen-
talized sympathetic neurons, promotes robust growth
of axons (Figure 3A). The axon growth-promoting effect
of NT-3 is evident at relatively low concentrations (10
ng/ml; Figure 3A). TrkA, not TrkC, mediates this effect
of NT-3, because immunoprecipitation and immunoblot
experiments indicate that, while TrkC levels in sympa-
thetic neurons are undetectable, these neurons express
high levels of TrkA, which can be activated effectively
by NT-3 (Figures 3B and 3C). In addition, an NT-3 variant
(NT-3mut; Ryden and Ibanez, 1996) that binds TrkC but
not TrkA is incapable of promoting axon outgrowth when
applied to distal axons (Figure 3D), although NT-3mut
does support growth and survival of TrkC-expressing
sensory neurons (data not shown). Thus, both NGF and
NT-3 signal via TrkA locally in distal axons to promote
axonal growth.
p75 Modulates NT-3/TrkA Signaling in Distal
Axons and Is Expressed in a Manner
Dependent upon Target-Derived NGF
The observation that NT-3 is less potent at promoting
axonal outgrowth than NGF (Figure 3A) led us to ques-
tion whether axonal sensitivity to NT-3 is modulated by
p75. It is interesting to note, in this regard, that levels
of p75 are very low in developing sympathetic neurons
as they project along NT-3-expressing vasculature and
other intermediate targets and rise sharply upon in-
nervation of final target fields (Verdi and Anderson, 1994;
Wyatt and Davies, 1995). Our finding that NT-3 is re-
quired for growth of sympathetic axons in vivo at times
when expression of p75 is very low, i.e., E15.0 and the
previous findings that p75 may decrease respon-
siveness to NT-3 (Davies et al., 1995; Lee et al., 1994b;
Wyatt et al., 1997), prompted us to test whether p75
modulates NT-3’s ability to promote axon growth. In-
deed, we found that NT-3 (10–100 ng/ml) elicits a 2- to
3-fold increase in axonal extension rates when added to
distal axons of compartmentalized sympathetic neurons
obtained from p75 mutant mice as compared to wild-
type controls (Figure 3E). The ability of NT-3 to evoke
an augmented axonal growth response in the absence
Figure 2. Sympathetic Innervation of Target Organs Is Reduced in of p75 is specific to NT-3, since axon extension rates
the Absence of NT-3 and NGF
in response to NGF were similar in the presence or
Sympathetic innervation is diminished in the heart (B), proximal absence of p75 (Figure 3E). Thus, p75 inhibits NT-3-
duodenum (D), and brown fat (F) in NT-3/ mice compared to lit-
mediated axonal extension in sympathetic neurons.termate controls (A, C, and E) at E16.5. Elimination of apoptotic cell
The findings that p75 expression peaks as axons in-death in NT-3/; Bax/ (G–H) and NGF/; Bax/ (I and J) mice
reveals the requirement of NT-3 and NGF for sympathetic innerva- nervate NGF-expressing target fields and that sympa-
tion of the heart at postnatal day 0.5. Scale bars, 100 m (A and B, thetic axons become less sensitive to NT-3 upon expres-
E and F); 250 m (C and D, G and H, I and J). n  3 (NT-3/), sion of p75 (Figure 3E) implicate p75 as a candidate
(NT-3/), 2 (NT-3/; Bax/), 2 (NT-3/; Bax/), n  3 (NGF/; for switching sympathetic neuron responsiveness from
Bax/), and n  4 (NGF/; Bax/).
NT-3 to NGF. We therefore considered the possibility
that one of the functions of target-derived NGF and
retrograde NGF/TrkA signaling is to control expression
NGF and NT-3 Coordinate Sympathetic Development
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Figure 3. Both NGF and NT-3 Signal Through TrkA in Distal Axons to Promote Axon Extension
(A) NT-3 and NGF promote axon outgrowth when added exclusively to distal axons of compartmentalized rat sympathetic neurons. Distal
axon compartments were photographed immediately following treatments with NGF or NT-3 (ng/ml) and every 24 hr for 2 days, and axon
length was measured using OpenLab software and expressed as average axon growth per day (m/day). (B) Both NGF and NT-3 can induce
TrkA phosphorylation in sympathetic neurons. Neurons were treated with media alone, NGF (10 ng/ml), or NT-3 (500 ng/ml) for 20 min. The
amount of phosphorylation of TrkA, Akt, and Erk1/2 in response to NGF and NT-3 at multiple time points including 5 min, 1 hr, 3 hr, and 8 hr
was similar (data not shown). Neuronal extracts were subjected to immunoprecipitation with an antibody directed against phosphotyrosine
followed by SDS-PAGE and immunoblotting with a TrkA-specific antibody. (C) Postnatal rat sympathetic neurons express high levels of TrkA
but little or no TrkC as compared to rat cortical cultures (compare second and third panels from top). Cortical cultures were established from
embryonic day 18 rat embryos and cultured for 3 days in vitro (DIV). Neuronal extracts were subjected to immunoblotting using antibodies
against P-Trk (Y490), TrkA, TrkC, and tubulin. (D) A mutant form of NT-3 (NT-3mut R31A  H33A; Ryden and Ibanez, 1996) that abolishes NT-3
binding to p75, TrkA, and TrkB but maintains its ability to bind TrkC demonstrates a lack of TrkC involvement in NT-3-mediated axon growth.
Experiments were done as described above with NT-3mut (100 ng/mL), NT-3 (100 ng/mL), or NGF (10 ng/mL) added exclusively to distal axons.
(E) NT-3-mediated axonal growth is enhanced in the absence of p75. Sympathetic neuronal cultures were established from postnatal day 0.5
BalbC and p75/ mice and grown in compartmentalized cultures in NGF-containing media for 7–10 DIV. Axonal growth assays were performed
as described above (A). For (A), (D), and (E), results are presented as mean  SEM from three independent experiments. Asterisk, p  0.01;
one-way ANOVA (for [A] and [D]) and two-way ANOVA (for [E]) followed by Tukey’s Multiple Comparisons Test. (F) NGF is necessary for
expression of p75 in vivo. RT-PCR results showing reduced levels of p75 mRNA in SCGs from NGF/; Bax/ mice as compared to NGF/;
Bax/ controls. TrkA levels were found to be equivalent between the two samples.
of p75, allowing target-derived NGF to exert dominant dramatically reduced in the absence of NGF is p75 (aver-
age 6-fold reduction, n  2). This result was obtainedcontrol over the sensitivity of axons to intermediate tar-
get-derived NT-3. Consistent with this notion are the in two separate microarray experiments and was con-
firmed using a sensitive RT-PCR assay (Figure 3F). SCGsprevious findings that exogenous NGF or NGF neutral-
ization modulates expression of p75 in sympathetic neu- from P0.5 NGF/; Bax/ mice have markedly reduced
levels of p75 mRNA as compared to their control NGF/:rons (Miller et al., 1994; Verdi and Anderson, 1994; Wyatt
and Davies, 1995; Zhou and Rush, 1996) and NGF but Bax/ littermates, while, in contrast, levels of TrkA
mRNA are similar in these mice. Thus, target-derivednot NT-3 can induce expression of p75 in mass cultures
of sympathetic neurons in vitro (Belliveau et al., 1997). NGF but not NT-3 supports p75 expression in devel-
oping sympathetic neurons in vivo which, in turn, trig-We found that NGF is indeed required in vivo for normal
expression of p75 (Figure 3F). This finding stems from gers a reduction in NT-3-mediated axon growth.
an Affymetrix microarray analysis of 36,000 known
genes and ESTs using cDNA prepared from SCGs iso- NGF but Not NT-3 Promotes Retrograde Survival
and Hypertrophy of Sympathetic Neuronslated from NGF/; Bax/ and NGF/; Bax/ animals
to identify genes whose expression requires NGF in vivo. It is striking that NT-3 null mice, like NGF null mice,
exhibit excess sympathetic neuronal cell death, and thisAmong the genes whose expression in SCGs is most
Cell
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Figure 4. NGF but Not NT-3 Supports Retrograde Survival and Soma Hypertrophy of Compartmentalized Sympathetic Neurons
(A) Compartmentalized sympathetic neuronal culture. Top panel, schematic view of compartmentalized culture chamber. Bottom panel,
neurofilament immunofluoresence of 7 DIV compartmentalized culture showing cell bodies (CB) and distal axons (DA). Scale bar, 1 mm.
(B and C) NT-3 cannot support survival of sympathetic neurons when applied exclusively to distal axons (B) but can when applied directly to
cell bodies (C). NT-3mut added directly to cell bodies does not promote survival (C, last bar). Sympathetic neurons grown in compartmentalized
cultures for 7–10 DIV in media containing NGF (100 ng/mL) were subjected to NGF withdrawal and treated with either NGF or NT-3 added
exclusively to distal axons (B) or cell bodies (C) at indicated concentrations (ng/mL) for 48 hr. Results are presented as mean  SEM from
three independent experiments. Asterisk, p  0.01; one-way ANOVA followed by Tukey’s Multiple Comparisons Test.
(D and E) NT-3 applied directly to cell bodies (E) but not distal axons (D) of compartmentalized sympathetic neurons promotes soma hypertrophy.
The broad spectrum caspase inhibitor BAF (50 M) was added to cell bodies to prevent cell death, and media alone or containing NGF or
NT-3 was added to distal axons (D) or cell bodies (E) at indicated concentrations (ng/ml) for 72 hr. Cell volume was determined by measuring
soma diameter using OpenLab software. Asterisk, p  0.01; one-way ANOVA followed by Tukey’s Multiple Comparisons Test.
(F) p75 does not modulate the ability of NT-3 to support retrograde survival. Sympathetic neuron cultures were established from embryonic
day 18.0 BalbC and p75/ mice and grown in compartmentalized cultures in NGF-containing media for 7–10 DIV. Neuronal survival was
assessed as described (B), and results are presented as mean  SEM from three independent experiments. Asterisk, p  0.05 significantly
different from untreated controls; two-way ANOVA followed by Tukey’s Multiple Comparisons Test.
may reflect survival-promoting roles of intermediate- even at an extremely high concentration (5000 ng/ml)
(Figure 4B). This is remarkable in light of the findingsand/or target-derived NT-3. Our finding that NT-3 is a
critical intermediate target-derived axon growth factor that NT-3 added either directly to mass cultures of sym-
pathetic neurons (Belliveau et al., 1997; Davies et al.,raises the alternate possibility, however, that neurons
may die in NT-3 null mice because of deficiencies in 1995) or to cell bodies of compartmentalized sympa-
thetic neurons (Figure 4C) can support survival, andtarget innervation and acquisition of target-derived NGF.
We therefore used compartmentalized cultures of sym- NT-3 added to distal axons can support axonal out-
growth (Figure 3A). Similarly, NT-3 added directly to cellpathetic neurons to determine the extent to which these
neurotrophins can directly support retrograde survival. bodies supports soma hypertrophy (Figure 4E), while,
in marked contrast, NT-3 added to distal axons is inca-Compartmentalized cultures were established using
NGF-containing media for 7 days in vitro (DIV) prior to pable of promoting soma hypertrophy (Figure 4D).
Hence, while NGF promotes robust survival and somawashing to remove NGF and then switching to media
containing either fresh NGF or NT-3. As reported pre- hypertrophy through retrograde signaling, NT-3 cannot.
We next considered the possibility that NT-3’s abilityviously (Ye et al., 2003), 10 ng/ml NGF applied exclu-
sively to distal axons supports maximal retrograde sur- to support retrograde survival is modulated or perhaps
inhibited by p75. This appears not to be the case, how-vival (Figure 4B). In sharp contrast, NT-3 is unable to
support survival when added exclusively to distal axons, ever, since a comparable amount of cell survival is ob-
NGF and NT-3 Coordinate Sympathetic Development
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Figure 5. NGF but Not NT-3 Signals Retrogradely via TrkA to Cell Bodies of Sympathetic Neurons
(A) Compartmentalized sympathetic neuronal culture. Top panel, schematic view of compartmentalized biochemistry chamber. Bottom panel,
neurofilament immunofluoresence of 7 DIV compartmentalized culture showing cell bodies (CB) and distal axons (DA). Scale bar, 1 mm.
(B) NGF and NT-3 promote phosphorylation of TrkA, Akt, and Erk1/2 in distal axons, but only NGF promotes retrograde activation of these
molecules in cell bodies of compartmentalized sympathetic neurons. Distal axons were treated with media alone or media containing NGF
(100 ng/ml) or NT-3 (500 ng/ml) for 8 hr. Cell body/proximal axon and distal axon lysates were prepared and subjected to immunoblotting
using antibodies against P-TrkA (Y490), P-Akt (Ser473), P-Erk 1/2, and p85.
(C) NGF but not NT-3 supports retrograde accumulation of P-TrkA in vivo. SCGs were dissected from NGF/; Bax/ and NGF/; Bax/
mice at postnatal day 0.5, homogenized in boiling Laemmli buffer, and proteins were resolved by SDS-PAGE and subjected to immunoblotting
using anti-P-Trk. The immunoblot was stripped and reprobed with anti-tubulin to normalize for protein amounts.
served in compartmentalized sympathetic neurons es- promote retrograde accumulation of P-TrkA, P-Erk-1/2,
and P-Akt within cell bodies (Figure 5B). Thus, whiletablished from p75 null mice and control mice when
exposed to either NGF or NT-3 exclusively on distal NT-3 is a potent activator of TrkA in distal axons and
can support TrkA-mediated axon outgrowth, it cannotaxons (Figure 4F). p75, therefore, does not prevent NT-3
from supporting retrograde survival, nor is it necessary promote retrograde TrkA signaling. These in vitro find-
ings are corroborated and extended by results of in vivofor NGF-dependent retrograde survival signaling.
experiments. In mice lacking both NGF and Bax (NGF/;
Bax/ mice), neurons are found to project axons alongNGF but Not NT-3 Supports Retrograde
intermediate targets (Glebova and Ginty, 2004), whichTrkA Signaling to Cell Bodies
express high levels of NT-3 (Francis et al., 1999). Yet,of Sympathetic Neurons
the amount of P-TrkA in cell bodies of neurons in theThe striking differences in the abilities of NGF and NT-3
SCG of NGF/; Bax/ mice is essentially undetectableto support retrograde survival and hypertrophy, despite
while, in contrast, robust P-TrkA is observed in neuronalboth being potent axon outgrowth factors, prompted us
cell bodies of Bax/ littermate controls (Figure 5C).to ask about potential differences in their capacities to
Taken together, these results indicate that the inabilitycontrol TrkA signaling and trafficking. Employing com-
of NT-3 to promote retrograde TrkA signaling is likelypartmentalized cultures (Figure 5A), we asked whether
to explain its inability to support retrograde survivaldifferences in NGF and NT-3’s capacity to support retro-
and hypertrophy.grade survival and hypertrophy are due to differences
in their abilities to activate retrograde TrkA signaling.
Addition of either NGF or NT-3 exclusively to distal axons NT-3 and NGF Differ in Their Ability to Support
TrkA Internalization and Signalingof compartmentalized cultures induced robust phos-
phorylation of TrkA and its effectors Erk1/2 and Akt from TrkA-Containing Endosomes
How can two neurotrophins, each of which promoteswithin distal axons (Figure 5B). However, in stark con-
trast to NGF, NT-3 stimulation of distal axons does not TrkA autophosphorylation and signaling in axons and
Cell
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axonal growth, differ in their capacities to support retro- TrkA phosphorylation (Figure 7B). Thus, although NT-3
can bind and activate cell surface TrkA, it clearly differsgrade TrkA signaling? It is possible that NGF and NT-3
differ in their abilities to promote TrkA internalization, from NGF in its inability to induce TrkA internalization
and, therefore, the formation of TrkA-containing signal-sorting of TrkA into transport or signaling vesicles,
and/or retrograde transport of TrkA-containing signaling ing endosomes. The lack of NT-3-mediated internaliza-
tion of TrkA can explain why this neurotrophin is incapa-endosomes. It is also possible that NGF and NT-3 acti-
vate distinct sets of TrkA effectors, the NT-3-activated ble of supporting retrograde TrkA signaling, survival,
hypertrophy, and gene expression in vitro and in vivo.set being incapable of supporting retrograde signaling.
Other possibilities exist, and they are not mutually ex- Since p75 has been shown to modulate the responses
of TrkA to NT-3, we next asked whether p75 influencesclusive.
To begin to distinguish among these possibilities, we the ability of TrkA to be internalized in response to NT-3.
Using the confocal immunofluorescence assay to visual-next asked whether NGF and NT-3 might signal from
distinct subcellular platforms, i.e., endosomes versus ize trafficking of activated TrkA in 293T cells which do
not express p75, we found that NGF but not NT-3 in-the plasma membrane. To address this question, an
immunofluorescence assay was employed to detect duced internalization of phosphorylated TrkA (Supple-
mental Figures S3B and S3C), suggesting that the pres-both TrkA and phosphorylated TrkA in cultured sympa-
thetic neurons. Sympathetic neurons transfected with a ence of p75 alone does not modulate the differential
internalization of TrkA. However, it is possible that 293TTrkA expression vector to elevate the levels of TrkA were
used for immunolocalization of the activated receptor cells may lack other cellular components that facilitate
the ability of p75 to modulate TrkA endocytosis. Thus,using P-Trk antibodies and confocal microscopy. Con-
sistent with our biochemical data (Figure 5B), both NGF in order to directly ask whether differential regulation of
TrkA internalization by NGF and NT-3 is altered in neu-and NT-3 stimulation result in activation of TrkA along
axons and at growth cones (Figure 6A). This analysis rons lacking p75, the cell surface biotinylation assay
using mass cultures of sympathetic neurons establishedof axons, however, does not allow us to assess the
subcellular localization and trafficking of P-TrkA. We from p75/ mice was employed. Analogous to the re-
sults in rat sympathetic neurons (Figure 7A), which ex-therefore examined the effects of ligand stimulation on
cell bodies, a method previously used to study TrkA press high levels of p75, we found that, while NGF
promotes internalization of TrkA in p75/ mouse sym-receptor internalization and trafficking in PC12 cells
(Shao et al., 2002). Consistent with previous PC12 cell pathetic neurons, NT-3 cannot (Figure 7C), despite the
fact that both ligands are equally capable of inducingexperiments, NGF application to sympathetic neurons
results in a rapid and sustained intracellular accumula- TrkA signaling, as seen by the equivalent levels of Akt
activation (Figure 7C). These results suggest that thetion of phosphorylated TrkA (Figure 6B). After 60 min of
NGF treatment, little or no P-TrkA remains on the plasma mechanisms underlying the differential trafficking of
TrkA by NT-3 and NGF appear to be either intrinsicallymembrane, while robust punctae of P-TrkA immunore-
related to TrkA or to be influenced by cellular compo-activity are found associated with intracellular organ-
nents other than the p75 neurotrophin receptor.elles. Similar to NGF treatments at short time points,
exposure of sympathetic neurons to NT-3 results in rapid
Discussionphosphorylation of TrkA localized to the cell surface
(Figure 6B). Yet, in dramatic contrast to NGF, NT-3 treat-
ment results in sustained localization of activated TrkA A fundamental question in developmental biology is how
a limited repertoire of growth factors and their receptorsat the cell surface (Figure 6B). Equally dramatic differ-
ences in TrkA trafficking were observed in experiments act in concert to coordinate the construction of morpho-
logically and functionally complex organs and tissues.in which PC12 cells and 293T cells overexpressing TrkA
were exposed to either NGF or NT-3 (Supplemental Fig- In this study, we show that the related neurotrophins
NGF and NT-3 signal through the same receptor, TrkA,ures S3A and S3B). Interestingly, NT-3 is highly effective
at activating ectopically expressed TrkC at the surface to coordinate distinct stages of sympathetic neuron de-
velopment. Remarkably, NGF and NT-3 control uniqueof sympathetic neurons within 5 min, while, at 60 min,
phosphorylated TrkC accumulates within intracellular aspects of sympathetic development through differen-
tial control of TrkA internalization and retrograde signal-organelles with a concomitant loss of activated receptor
from the cell surface (Figure 6C). Thus, while both NGF ing. Thus, intermediate target-derived NT-3 signals via
cell surface TrkA to support axon growth but not ret-and NT-3 activate TrkA on the plasma membrane, these
neurotrophins have markedly different effects on traf- rograde survival, whereas final target-derived NGF
supports not only local axon growth but also survival,ficking of the activated receptor.
To further test the possibility that NGF and NT-3 differ anabolic responses, and gene expression through retro-
grade signaling. Interestingly, retrograde NGF/TrkA sig-in their ability to promote internalization of P-TrkA and
the formation of TrkA containing signaling endosomes, naling leads to upregulation of p75, which in turn dimin-
ishes NT-3/TrkA signaling in axons. We propose thatwe employed a cell surface biotinylation assay, which
provides a measure of ligand-dependent internalization this hierarchical neurotrophin signaling cascade facili-
tates the extension of axons from intermediate targetsof endogenous TrkA in cultured sympathetic neurons.
We found that NGF induces robust internalization of into nearby target fields. Furthermore, the differential
control of TrkA trafficking ensures that target-derivedbiotinylated TrkA receptors in sympathetic neurons (Fig-
ure 7A), while, in sharp contrast, NT-3 cannot. Both NGF NGF and not intermediate target-derived NT-3 is solely
responsible for retrograde survival signaling, therebyand NT-3 activated TrkA signaling under the conditions
of this assay as indicated by comparable amounts of enabling proper systems matching.
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Figure 6. NGF and NT-3 Differentially Regulate Trafficking of Phosphorylated TrkA
(A and B) Both NGF and NT-3 promote phosphorylation of TrkA at sympathetic neuron growth cones (A) but induce differential P-TrkA
localization at cell bodies following ligand treatment (B). Sympathetic neurons grown in mass culture were transfected with TrkA to enhance
detection of its subcellular distribution in neurons treated with either NGF or NT-3. Following NGF withdrawal, neurons were treated with NGF
(50 ng/mL), NT-3 (500 ng/mL), or media alone for 60 min (A and B) or 5 min (B) and processed for TrkA and P-Trk immunofluoresence.
(C) NT-3 induces trafficking of activated TrkC from the cell surface to intracellular organelles in sympathetic neurons transfected with GFP
and TrkC. Neurons were treated with NT-3 (50 ng/mL) for either 5 or 60 min and then immunostained for P-Trk and GFP. All images were
obtained using a laser scanning confocal microscope (Zeiss LSM510) with a 100 Apochromat oil immersion objective lens at 3 zoom.
Both NGF and NT-3 Activate TrkA in Distal Axons to distal axons of sympathetic neurons. Moreover, NT-3
is required in vivo for sympathetic axon extension alongto Support Axon Growth
Both NT-3 and NGF activate TrkA and its downstream intermediate targets, whereas both NT-3 and NGF are
critical for end-organ innervation. While NT-3 is a keyeffector pathways locally in axons, and both ligands
promote robust axon outgrowth when added exclusively regulator of sympathetic axon growth, this neurotrophin
Cell
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Figure 7. NGF but Not NT-3 Promotes Internalization of TrkA
(A) NGF but not NT-3 promotes internalization of biotinylated TrkA in mass cultures of sympathetic neurons. Neurons were biotinylated and
then incubated at 37C for 30 min in media alone (lanes 1 and 3) or media containing NGF (50 ng/ml; lane 4) or NT-3 (1000 ng/ml; lane 5) to
allow for internalization of cell surface proteins. The remaining cell surface biotin was cleaved by reducing its disulfide linkage (for all samples
except lane 1, which represents total biotinylated TrkA). Lane 2 shows a control for the efficiency of the stripping procedure, in which cells
were kept at 4C after treatment with biotin and then subjected to biotin cleavage. Neurons were subsequently lysed, biotinylated proteins
were precipitated with Neutravidin beads, and complexes were immunoblotted with anti-TrkA (Chemicon). Supernatants were immunoblotted
with an antibody directed against the p85 subunit of PI-3 kinase for normalization.
(B) NGF and NT-3 induce phosphorylation of biotinylated TrkA. Sympathetic neurons were grown in mass culture and biotinylated as described
in (A). Neurons were then incubated at 37C for 30 min in media alone or media containing NGF (50 ng/ml) or NT-3 (1000 ng/ml) and lysates
immunoblotted using antibodies directed against P-TrkA and p85.
(C) NGF but not NT-3 promotes internalization of TrkA in the absence of p75. Mass cultures of sympathetic neurons were established from
p75/ mice at postnatal day 1 and grown for 3 DIV followed by neurotrophin starvation in the presence of BAF (50 M) for 2 days. Neurons
were then subjected to the cell-surface biotinylation assay as described above to assess internalization of TrkA in the absence of any added
ligands or in the presence of NGF (50 ng/ml) or NT-3 (1000 ng/ml). Supernatants obtained after precipitation of biotinylated proteins with
Neutravidin beads were subjected to immunoblotting using P-Akt (Ser 473) and TH for normalization.
is unlikely to be the sole axonal growth factor for sympa- NGF and NT-3 Differ in Their Ability to Promote
TrkA Internalization, Retrogradethetic neurons extending along intermediate targets,
since a substantial amount of axonal growth remains in Signaling, and Survival
Our findings indicate that NGF dominantly repressesNT-3 null animals, and approximately 50% of neurons
from NT-3 null mice do ultimately acquire target-derived NT-3 signaling and that NGF but not NT-3 supports
retrograde survival because of NGF’s unique ability toNGF and survive (Ernfors et al., 1994; Farinas et al.,
1994; Francis et al., 1999). Thus, NT-3 likely acts in con- support retrograde TrkA signaling. How can two struc-
turally related neurotrophins, both of which act locallycert with other growth-promoting factors to support ax-
onal extension along the vasculature. One excellent can- on distal axons to activate the same receptor, TrkA, and
promote axonal outgrowth, differ so dramatically in theirdidate is artemin, a member of the GDNF family,
because, like NT-3, artemin is expressed along the vas- abilities to signal retrogradely to support survival, hyper-
trophy, and gene expression? We have recently shownculature, and exogenous artemin promotes sympathetic
axonal growth in vitro and in vivo (Honma et al., 2002). that NGF supports retrograde survival through a mecha-
nism that is dependent upon retrograde TrkA signalingIt will be important in future studies to assess the relative
in vivo contributions of artemin and other factors, such and at least partly dependent upon retrograde transport
of NGF (Ye et al., 2003), which is cotransported withas VEGFs, to growth of axons as they extend along the
vasculature and into final target fields. TrkA (Tsui-Pierchala and Ginty, 1999). Here, we report
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that NGF but not NT-3 promotes the retrograde accumu- pending on the distance between the soma and target
lation of phosphorylated TrkA and at least some of its organ, does not. Thus, a scenario whereby retrograde
effectors within cell bodies of sympathetic neurons. Sur- survival of sympathetic neurons is supported solely by
prisingly, the inability of NT-3 to support retrograde bio- end organ-derived NGF and not intermediate target-
chemical signaling, survival, and p75 expression can derived NT-3 enables efficient and accurate systems
be explained by the finding that NT-3 cannot support matching.
internalization of TrkA. This was unexpected, because
other findings have indicated that TrkA catalytic activity p75 Expression Enables Sympathetic Neurons
is required for its internalization (data not shown), and, to Switch Sensitivity from NT-3 to NGF
as shown here, both NGF and NT-3 can promote TrkA A central principle of axon guidance is that axons of
autophosphorylation in distal axons. Thus, autophos- long projection neurons navigate in a stepwise fashion
phorylation is necessary but not sufficient for TrkA inter- from a series of intermediate targets to reach final tar-
nalization in sympathetic neurons. It must be noted, gets (Tessier-Lavigne and Goodman, 1996). A growing
however, that we assessed tyrosine phosphorylation of body of evidence indicates that, as axons extend toward
TrkA using a Y490-specific antibody, and it remains pos- final targets, they employ mechanisms that dynamically
sible that phosphorylation of other crucial tyrosine resi- modulate their responses to extracellular cues en route.
dues on TrkA are differentially regulated by NGF and For example, as vertebrate commissural axons cross the
NT-3. There is precedence for multiple EGF-like ligands midline, they switch responsiveness from the attractant
inducing differential patterns of tyrosine phosphoryla- netrin to the repellent slit, an effect that is mediated at
tion of a common receptor kinase, ErbB4, leading to the least in part by the silencing effect of slit on netrin/DCC
recruitment of unique sets of cytoplasmic effectors and signaling (Stein and Tessier-Lavigne, 2001). In Drosoph-
activation of different intracellular signaling cascades ila, an intracellular protein trafficking-based mechanism
(Sweeney et al., 2000). A similar mechanism leading to delivers the slit receptor Robo to the cell surface after
recruitment of distinct signaling effectors or endocytic commissural axons cross the midline, so that these ax-
adaptors to trafficking motifs within TrkA may underlie ons respond to slit only after midline crossing (Dickson,
the differential effects of NGF and NT-3 on TrkA internal- 2002). Commissural axons crossing the midline may also
ization. In any case, the inability of NT-3 to support use local protein synthesis to gain responsiveness to a
TrkA internalization is likely to account for its inability new set of guidance cues after they have crossed (Brittis
to promote retrograde TrkA signaling, expression of p75, et al., 2002). A central theme in all of these examples is
and retrograde control of survival and hypertrophy. that axons must make complex decisions at intermedi-
Our finding that NT-3 supports local axonal signaling ate targets, and growth cones must employ resourceful
but not retrograde TrkA signaling or survival is consis- mechanisms to advance along their trajectories toward
tent with the previous findings that massive neuronal final target fields.
apoptosis within the SCG of NGF null mice is observed Many sympathetic axons grow in close proximity to
at E17.5, a time at which NT-3 is both expressed in the blood vessels, an intermediate target that expresses
vasculature and found in the present study to support
abundant levels of NT-3, en route to their final targets.
local axonal growth in vivo. Moreover, loss of one or
What makes sympathetic axon growth cones leave inter-
both alleles of NT-3 does not exacerbate cell death
mediate target regions to invade final peripheral targets?
caused by the absence of NGF (Francis et al., 1999).
We propose a model in which a hierarchical neuro-These findings, taken together, indicate that NT-3 can-
trophin signaling cascade coordinates the projectionnot substitute for NGF to support sympathetic neuron
of sympathetic neurons. In this model, axons exitingsurvival, and, therefore, the physiological function of
developing sympathetic ganglia closely follow bloodNT-3 is to support axonal growth but not survival of
vessels and other intermediate targets toward the pe-developing sympathetic neurons. This stands in marked
riphery. NT-3 derived from vascular smooth muscle cellscontrast to NGF, which serves as both an essential tar-
promotes activation of TrkA on sympathetic axons,get-derived axonal growth factor (Glebova and Ginty,
allowing for rapid and robust axonal extension along2004) and a retrograde survival factor. Our findings,
the vasculature at times when p75 levels are low. Astherefore, support the idea that excess sympathetic
axons approach end organs and begin to acquire target-neuron cell death observed in NT-3/ mice (Ernfors et
derived NGF, the ensuing retrograde NGF/TrkA signal-al., 1994; Farinas et al., 1994; Francis et al., 1999) occurs
ing promotes survival, anabolic responses, and expres-not because NT-3 is a survival factor but rather because
sion of p75. The increase in p75, in turn, diminishesit is required for axonal growth and target innervation
axonal responsiveness of TrkA to NT-3, enabling target-and, hence, the acquisition of target-derived NGF. These
derived NGF to become the dominant axonal growthfindings also raise an important question regarding the
factor. One key prediction of this model is that sympa-extent to which intermediate targets, such as the vascu-
thetic innervation of end organs would be diminishedlature, are needed for neuronal survival. Indeed, it seems
in the absence of p75. Indeed, decreased sympatheticto us advantageous that intermediate target-derived
innervation of several targets, including pineal gland,growth factors such as NT-3 not serve as retrograde
sweat glands, and brown fat, have been reported insurvival factors in order to ensure robust competition
postnatal and adult p75/ mice (Brennan et al., 1999;for final target-derived survival factors such as NGF. In
Lee et al., 1994a). Moreover, we have found major defi-this way, the size of the end-organ target field dictates
cits in innervation of the heart and small intestines inthe appropriate size of the neuronal population, whereas
E16.5 p75 mutant mice (Supplemental Figure S4). Thus,the size of intermediate targets, which for the vascula-
ture can vary dramatically in both mass and length de- through retrograde activation of expression of p75, NGF/
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mouse AlexaFluor 488 (Molecular Probes) and anti-rabbit AlexaFluorTrkA signaling dominantly represses axonal NT-3/TrkA
594 (Molecular Probes) were utilized for immunofluorescence detec-signaling, thereby facilitating the extension of axons into
tion as previously described (Shao et al., 2002). All images werefinal target fields.
processed with Adobe PhotoShop.
Taken together, our findings indicate that NT-3 and
NGF coordinate sympathetic axon growth, innervation Internalization Assay
of targets, and survival in a manner dependent on the Internalization of TrkA was analyzed using a cell-surface biotinyla-
tion assay. Briefly, sympathetic neurons were grown in mass cul-differential control of TrkA internalization, trafficking,
tures in NGF-containing media for 7 DIV and then starved of neuro-and retrograde signaling. In a broader sense, it is re-
trophins in media containing BAF (50 M) for 2 days. Neurons weremarkable that emerging evidence indicates that many
subjected to biotinylation on ice with the reversible membrane-
or perhaps most growth factor receptors appear to have impermeable derivative of biotin (sulfo-NHS-S-S-biotin from Pierce;
evolved to mediate responses of more than one ligand. 1.5 mg/mL in PBS). Internalization was allowed to occur by incuba-
We propose that distinct growth factors acting upon a tion at 37C with media containing no added neurotrophins, NGF
(50 ng/mL), or NT-3 (1000 ng/mL). The remaining cell-surface biotinlimited number of shared receptors coordinate complex
was cleaved by reducing its disulfide linkage with glutathione cleav-developmental events in the nervous system and else-
age buffer and neurons lysed with RIPA buffer. Biotinylated proteinswhere through their differential control of receptor inter-
were precipitated using UltraLink immobilized Neutravidin beads
nalization and trafficking, key determinants of both the (Pierce, Rockford, IL), eluted from the beads with boiling Laemmli
nature and duration of receptor activity and cellular re- buffer, resolved by SDS-PAGE, and immunoblotted with an antibody
sponse. directed against TrkA (Chemicon).
Whole-Mount Tyrosine Hydroxylase ImmunohistochemistryExperimental Procedures
Whole-mount tyrosine hydroxylase (TH) immunohistochemistry was
performed as previously described (Glebova and Ginty, 2004). WeAnimals
did not detect any differences in TH levels in SCGs isolated fromp75 mutant mice on a mixed background of 129 and Balb/C strains
NGF/; Bax/ and NGF/; Bax/ mice (Supplemental Figure S1).(targeted deletion of exon III; Lee et al., 1992) and control Balb/C
mice were obtained from Jackson Laboratory, Bar Harbor, Maine.
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